Articles by Phil Wagner - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Phil Wagner

Practical Considerations for Demonstrating Drug Substance Uniformity

The authors describe considerations and best practices for meeting drug substance uniformity.
Apr 1, 2011

The authors describe considerations and best practices for meeting drug substance uniformity.

ADVERTISEMENT

ADVERTISEMENT

Click here